Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse.

The concentration dependence and tissue distribution of high density lipoprotein (HDL) cholesteryl ester and apolipoprotein (apo) transport were determined in apoA-I knockout mice (apoA-I-/-) that lack normal HDL in plasma. Rates of HDL cholesteryl ester clearance were highly sensitive to plasma HDL cholesteryl ester concentrations with clearance rates falling by 80% in the liver and by 95% in the adrenal glands when plasma HDL cholesteryl ester concentrations were acutely raised to levels normally seen in control mice (approximately 50 mg/dl). With the exception of the brain, saturable HDL cholesteryl ester uptake was demonstrated in all tissues of the body, with the adrenal glands and liver manifesting the highest maximal transport rates (Jm). The plasma concentration of HDL cholesteryl ester necessary to achieve half-maximal transport (Km) equaled 4 mg/dl in the adrenal glands and liver; as a consequence, HDL cholesteryl ester uptake by these organs is maximal (saturated) at normal plasma HDL concentrations in the mouse. When expressed per whole organ, the liver was the most important site of HDL cholesteryl ester clearance accounting for approximately 72% of total HDL cholesteryl ester turnover at normal plasma HDL concentrations. HDL cholesteryl ester transporter activity and scavenger receptor type B1 (SR-BI) protein and mRNA levels were not up-regulated in any organ of apoA-I-/- mice even though these animals lack normal HDL.

[1]  D. Kearney,et al.  Diet modification alters plasma HDL cholesterol concentrations but not the transport of HDL cholesteryl esters to the liver in the hamster. , 1997, Journal of lipid research.

[2]  P. Connell,et al.  Alternative forms of the scavenger receptor BI (SR-BI). , 1997, Journal of lipid research.

[3]  L. Woollett,et al.  Kinetic parameters for high density lipoprotein apoprotein AI and cholesteryl ester transport in the hamster. , 1997, The Journal of clinical investigation.

[4]  E. Edelman,et al.  Regulation by Adrenocorticotropic Hormone of the in Vivo Expression of Scavenger Receptor Class B Type I (SR-BI), a High Density Lipoprotein Receptor, in Steroidogenic Cells of the Murine Adrenal Gland* , 1996, The Journal of Biological Chemistry.

[5]  A. Tall,et al.  Scavenger Receptor BI (SR-BI) Is Up-regulated in Adrenal Gland in Apolipoprotein A-I and Hepatic Lipase Knock-out Mice as a Response to Depletion of Cholesterol Stores , 1996, The Journal of Biological Chemistry.

[6]  A. Rigotti,et al.  Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. , 1996, The Journal of clinical investigation.

[7]  K. Marotti,et al.  Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Helen H. Hobbs,et al.  Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.

[9]  J. Herz,et al.  Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Fielding,et al.  Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.

[11]  J. Willard,et al.  Adenovirus‐Mediated Transfer of a Gene Encoding Human Apolipoprotein A‐I Into Normal Mice Increases Circulating High‐Density Lipoprotein Cholesterol , 1994, Circulation.

[12]  H. Lodish,et al.  Expression cloning of SR-BI, a CD36-related class B scavenger receptor. , 1994, The Journal of biological chemistry.

[13]  C. Sloop,et al.  Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations. , 1993, Biochimica et biophysica acta.

[14]  J. Horton,et al.  Dietary fatty acids regulate hepatic low density lipoprotein (LDL) transport by altering LDL receptor protein and mRNA levels. , 1993, The Journal of clinical investigation.

[15]  A. Tall,et al.  Plasma cholesteryl ester transfer protein. , 1993, Journal of lipid research.

[16]  R. Gerard,et al.  Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Gotto,et al.  High density lipoprotein interconversions in rat and man as assessed with a novel nontransferable apolipopeptide. , 1993, The Journal of biological chemistry.

[18]  N. Maeda,et al.  Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  W. Willett,et al.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.

[20]  S. Eisenberg,et al.  Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. , 1991, The Journal of clinical investigation.

[21]  M. Brown,et al.  Low density lipoprotein receptor-related protein mediates endocytosis of monoclonal antibodies in cultured cells and rabbit liver. , 1990, The Journal of biological chemistry.

[22]  D. Gordon,et al.  High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.

[23]  P. Wilson,et al.  High Density Lipoprotein Cholesterol, Total Cholesterol Screening, and Myocardial Infarction: The Framingham Study , 1988, Arteriosclerosis.

[24]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[25]  S. Georas,et al.  Effect of dietary fat saturation on plasma lipoproteins and high density lipoprotein metabolism of the rhesus monkey. , 1987, The Journal of clinical investigation.

[26]  R. Pittman,et al.  A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. , 1987, The Journal of biological chemistry.

[27]  N. Rifai,et al.  Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum. , 1986, Clinical chemistry.

[28]  J. Dietschy,et al.  Kinetic constants for receptor-dependent and receptor-independent low density lipoprotein transport in the tissues of the rat and hamster. , 1986, The Journal of clinical investigation.

[29]  D. B. Zilversmit,et al.  Comparison of various methods for in vitro cholesteryl ester labeling of lipoproteins from hypercholesterolemic rabbits. , 1984, Biochimica et biophysica acta.

[30]  D. Steinberg,et al.  Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Steinberg,et al.  Tissue sites of degradation of apoprotein A-I in the rat. , 1983, The Journal of biological chemistry.

[32]  J. Parks,et al.  Different kinetic fates of apolipoproteins A-I and A-II from lymph chylomicra of nonhuman primates. Effect of saturated versus polyunsaturated dietary fat. , 1982, Journal of lipid research.

[33]  O. Stein,et al.  Biological labeling of very low density lipoproteins with cholesteryl linoleyl ether and its fate in the intact rat. , 1980, Biochimica et biophysica acta.

[34]  C. Blum,et al.  High density lipoprotein metabolism in man. , 1977, The Journal of clinical investigation.

[35]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[36]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoproteins. , 1972, Biochimica et biophysica acta.

[37]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.

[38]  W Young,et al.  Ischemic Heart Disease, Atherosclerosis, and Longevity , 1966, Circulation.

[39]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[40]  W. Beltz,et al.  Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits. , 1991, The Journal of clinical investigation.

[41]  G. S. Shelness,et al.  Measurement of apolipoprotein mRNA by DNA-excess solution hybridization with single-stranded probes. , 1986, Methods in enzymology.

[42]  O. Stein,et al.  Synthesis of ether analogs of lipoprotein lipids and their biological applications. , 1986, Methods in enzymology.